Could a simple blood test predict clot risk in antiphospholipid syndrome?

NCT ID NCT07743242

Recruiting now Knowledge-focused Sponsor: New Valley University Source: ClinicalTrials.gov ↗

First seen Aug 03, 2026 · Last updated Aug 11, 2026 · Updated 3 times

Summary

This study asks whether autoimmune hemolytic anemia (AIHA) is linked to a higher risk of blood clots in people with antiphospholipid syndrome (APS). Researchers will compare the number of thrombotic events in APS patients who have AIHA versus those who do not. The study will enroll 230 adults with APS and signs of hemolysis, using blood tests to identify AIHA.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Blood tests (hemoglobin and Coombs test) to detect autoimmune hemolytic anemia
What this could lead to: If a link is found, doctors might monitor AIHA more closely in APS patients to help prevent blood clots.
What could go wrong: This is an observational study, so it cannot prove cause and effect. The findings may not apply to all APS patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTI PHOSPHOLIPID SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

antiphospholipid syndrome autoimmune hemolytic anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANTI PHOSPHOLIPID SYNDROME

Contacts and locations

Locations

New Valley University
RECRUITING

Al Khārjah, Kharga Oasis, 72511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.